These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6094003)

  • 1. Evaluation of vindesine in patients with refractory small cell lung cancer.
    Chang AY; Witte RS; Tormey DC; Ramirez G
    Cancer Treat Rep; 1984 Nov; 68(11):1407-8. PubMed ID: 6094003
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of vindesine in patients with small cell lung carcinoma.
    Natale RB; Gralla RJ; Wittes RE
    Cancer Treat Rep; 1981; 65(1-2):129-31. PubMed ID: 6261946
    [No Abstract]   [Full Text] [Related]  

  • 3. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
    Niederle N; Schütte J; Schmidt CG; Seeber S
    Cancer Treat Rep; 1984 May; 68(5):791-2. PubMed ID: 6327037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.
    Osterlind K; Dombernowsky P; Sørensen PG; Hansen HH
    Cancer Treat Rep; 1981; 65(3-4):245-8. PubMed ID: 6263469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vindesine: an effective agent in the treatment of non-small cell lung cancer.
    Furnas BE; Williams SD; Einhorn LH; Cobleigh MA
    Cancer Treat Rep; 1982 Sep; 66(9):1709-11. PubMed ID: 7116347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
    Joss RA; Brunner KW; Goldhirsch A
    Cancer Treat Rep; 1982 Oct; 66(10):1873-4. PubMed ID: 6290051
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of vindesine in adenocarcinoma of the lung.
    Sledge GW; Clark GM; Von Hoff DD
    Cancer Treat Rep; 1984 Mar; 68(3):557-8. PubMed ID: 6704986
    [No Abstract]   [Full Text] [Related]  

  • 12. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
    Osterlind K; Hørbov S; Dombernowsky P; Rørth M; Hansen HH
    Cancer Treat Rep; 1982 Feb; 66(2):305-9. PubMed ID: 7055816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of vinblastine in small cell carcinoma of the lung.
    Sörenson S; Osterlind K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1983 Mar; 67(3):293-5. PubMed ID: 6299548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase II study of vindesine in patients with carcinoma of the lung and metastatic pulmonary tumor].
    Shibuya M; Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Shimabukuro Z
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1808-13. PubMed ID: 6307176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
    Luedke SL; Luedke DW; Petruska P; Broun GO; Reed G; Leavitt J
    Cancer Treat Rep; 1982 Jun; 66(6):1409-11. PubMed ID: 7083243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study.
    Miller TP; Weick JK; Grozea PN; Carlin DA
    Cancer Treat Rep; 1982 Mar; 66(3):553-6. PubMed ID: 6277487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
    Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
    Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
    [No Abstract]   [Full Text] [Related]  

  • 19. Initial clinical studies of vindesine.
    Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II evaluation of vindesine for patients with advanced colorectal carcinoma.
    Saiers JH; Slavik M; McKinney DR
    Cancer Treat Rep; 1982 Mar; 66(3):583-4. PubMed ID: 7060047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.